InsidersTradesSigma
Follow the 아리바이오LAB share price and the full insider trade history of the company, a listed issuer based in South Korea. Shares are quoted on the KR market, under the oversight of DART (FSS). Market capitalisation: €263.7m. The latest transaction was reported on 15 July 2026 (Other). Among the most active insiders: 아리바이오LAB. Every trade is openly available.
Analysts rate 아리바이오LAB Hold (neutral), based on 1 analysts. Average price target: US$1.35.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
AribioLAB 是一家在 XKRX 市场上市的公司，专注于生物制药解决方案的开发。它致力于医疗保健领域的研究和创新。